ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents

ClinicalTrials.gov ID: NCT03338920

Public ClinicalTrials.gov record NCT03338920. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents

Study identification

NCT ID
NCT03338920
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Currax Pharmaceuticals
Industry
Enrollment
159 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • sumatriptan nasal powder Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 1, 2017
Primary completion
Apr 10, 2022
Completion
Apr 10, 2022
Last update posted
Jul 23, 2023

2017 – 2022

United States locations

U.S. sites
40
U.S. states
21
U.S. cities
36
Facility City State ZIP Site status
Phoenix Children's Hospital Phoenix Arizona 85016
Advanced Research Center Anaheim California 92805
Axis Clinical Trial Network Los Angeles California 90017
Axis Clinical Trial Network Los Angeles California 90036
Children's Hospital Colorado Aurora Colorado 80045
Alpine Clinical Research Center, Inc. Boulder Colorado 80301
Colorado Springs Neurological Associates Colorado Springs Colorado 80907
Mountain View Clinical Research, Inc. Denver Colorado 80209
New England Institute for Neurology and Headache Stamford Connecticut 06905
International Research Partners, LLC Doral Florida 33166
Direct Helpers Research Center Hialeah Florida 33012
Eastern Research, Inc. Hialeah Florida 33013
South Florida Clinical Trials Hialeah Florida 33016
Allied Biomedical Research Institute Miami Florida 33155
Premiere Research Institute West Palm Beach Florida 33407
Clinical Integrative Research Center of Atlanta Atlanta Georgia 30328
St. Luke's Health System Meridian Idaho 83642
AMITA Health Medical Group Pediatric Neurology Hoffman Estates Illinois 60169
UK Headache Center Kentucky Neuroscience Institute Lexington Kentucky 40536
Michigan Head Pain and Neurological Institute Ann Arbor Michigan 48104
Center for Pharmaceutical Research, LLC Kansas City Missouri 64114
Clinvest Research, LLC. Springfield Missouri 65810
Meridian Clinical Research, LLC Hastings Nebraska 68901
Meridian Clinical Research, LLC Lincoln Nebraska 68510
Bio Behavioral Health Toms River New Jersey 08755
Dent Neurosciences Research Center Amherst New York 14226
New York Clinical Trials Brooklyn New York 11201
NYCT, A Member of the Alliance, Inc. New York New York 10022
Headache Wellness Center Greensboro North Carolina 27405
Hometown Urgent Care and Research Cincinnati Ohio 45215
Cincinnati Children's Hospital Cincinnati Ohio 45229
Hometown Urgent Care and Research Dayton Ohio 45424
OK Clinical Research, LLC Edmond Oklahoma 73034
Lynn Health Science Institute Norman Oklahoma 73072
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Preferred Primary Care Physicians, Inc. Pittsburgh Pennsylvania 15236
Road Runner Research San Antonio Texas 78249
Olympus Family Medicine Salt Lake City Utah 84117
South Ogden Family Medicine/CCT Research South Ogden Utah 84405
Northwest Clinical Research Center Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03338920, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 23, 2023 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03338920 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →